Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis

Filiacions

Hernández-Boluda JC:

Hematology Department, Hospital Clínico, Valencia, Spain

Pereira A:

Transfusion Service, Hospital Clínic, Barcelona, Spain

Correa JG:

Hematology Department, Hospital Clinic, Barcelona, Spain

Alvarez-Larrán A:

Hematology Department, Hospital del Mar, Barcelona, Spain

Ferrer-Marín F:

Hematology and Medical Oncology Department, Hospital Morales Meseguer, Murcia, Spain

Raya JM:

Hematology Department, Hospital Universitario de Canarias, Tenerife, Spain

Martínez-López J:

Hematology Department, Hospital 12 de Octubre, Madrid, Spain

Pérez-Encinas M:

Hematology Department, Hospital Clínico, Santiago de Compostela, Spain

Estrada N:

Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain

Velez P:

Hematology Department, Hospital Duran i Reynals, Hospitalet de Llobregat, Spain

Fox ML:

Hematology Department, Hospital Vall d'Hebron, Barcelona, Spain

García-Gutiérrez V:

Hematology Department, Hospital Ramón y Cajal, Madrid, Spain

Payer A:

Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain

Kerguelen A:

Hematology Department, Hospital La Paz, Madrid, Spain

Cuevas B:

Hematology Department, Hospital Universitario de Burgos, Burgos, Spain

Durán MA:

Hematology Department, Hospital Son Espases, Mallorca, Spain

Ramírez MJ:

Hematology Department, Hospital de Jerez, Cádiz, Spain

Gómez-Casares MT:

Hematology Department, Hospital Dr Negrín, Las Palmas de Gran Canaria, Spain

Mata-Vázquez MI:

Hematology Department, Hospital Costa del Sol, Marbella, Spain

Mora E:

Hematology Department, Hospital La Fe, Valencia, Spain

Martínez-Valverde C:

Hematology Department, Hospital Sant Pau, Barcelona, Spain

Gómez M:

Hematology Department, Hospital Clínico, Valencia, Spain

Cervantes F:

Hematology Department, Hospital Clinic, Barcelona, Spain